Baird Downgrades HCA Healthcare to Neutral, Lowers Price Target to $336

Benzinga · 04/15 11:35
Baird analyst Michael Ha downgrades HCA Healthcare (NYSE:
HCA) from Outperform to Neutral and lowers the price target from $396 to $336.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.